August 7, 2013 · 12:10 pm

SJC: State-law design-defect claims that turn on the adequacy of a drug’s warnings are pre-empted by federal law under Federal Food, Drug, and Cosmetic Act.


Opinion:
MUTUAL PHARMACEUTICAL CO., INC.
v.
BARTLETT

Comments Off on SJC: State-law design-defect claims that turn on the adequacy of a drug’s warnings are pre-empted by federal law under Federal Food, Drug, and Cosmetic Act.

Filed under Current Events